Spyre Therapeutics Inc. Common Stock (SYRE)
FairStock Score: 11/100 — RISKY
| Current Price | $70.04 |
| Market Cap | $6,04,16,05,632 |
| P/E Ratio | — |
| ROE | -25.17% |
| Dividend Yield | —% |
| Sector | Healthcare |
Data from SEC filings. Not investment advice. Scoring methodology
FairStock Score: 11/100 — RISKY
| Current Price | $70.04 |
| Market Cap | $6,04,16,05,632 |
| P/E Ratio | — |
| ROE | -25.17% |
| Dividend Yield | —% |
| Sector | Healthcare |
Data from SEC filings. Not investment advice. Scoring methodology